1. Home
  2. CLW vs NNNN Comparison

CLW vs NNNN Comparison

Compare CLW & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$19.40

Market Cap

338.7M

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$6.18

Market Cap

340.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
NNNN
Founded
1926
2021
Country
United States
Germany
Employees
3710
N/A
Industry
Paper
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.7M
340.2M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
CLW
NNNN
Price
$19.40
$6.18
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $20.33
N/A
AVG Volume (30 Days)
109.0K
★ 241.6K
Earning Date
04-28-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,555,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.16
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
★ 12.42
N/A
52 Week Low
$11.73
$5.13
52 Week High
$23.59
$51.33

Technical Indicators

Market Signals
Indicator
CLW
NNNN
Relative Strength Index (RSI) 38.89 40.72
Support Level $19.25 $5.13
Resistance Level $20.80 $12.10
Average True Range (ATR) 0.83 0.53
MACD -0.18 0.19
Stochastic Oscillator 3.91 57.69

Price Performance

Historical Comparison
CLW
NNNN

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: